Prognostic Impact of DHRS9 Overexpression in Pancreatic Cancer
Huang-bao Li,1 Jun Zhou,1 Fengqing Zhao,1 Jiayin Yu,2 Longsheng Xu3 1Department of Hepatobiliary and Pancreatic Surgery, First Hospital of Jiaxing, First Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, People’s Republic of China; 2Department of Pathology, First Hospital of Ji...
Main Authors: | Li H, Zhou J, Zhao F, Yu J, Xu L |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/prognostic-impact-of-dhrs9-overexpression-in-pancreatic-cancer-peer-reviewed-article-CMAR |
Similar Items
-
FAM172A inhibits EMT in pancreatic cancer via ERK-MAPK signaling
by: Ying Chen, et al.
Published: (2020-02-01) -
Histone deacetylase 6 is overexpressed and promotes tumor growth of colon cancer through regulation of the MAPK/ERK signal pathway
by: Zhang SL, et al.
Published: (2019-04-01) -
The Olfactory Receptor Family 2, Subfamily T, Member 6 (OR2T6) Is Involved in Breast Cancer Progression via Initiating Epithelial-Mesenchymal Transition and MAPK/ERK Pathway
by: Ming Li, et al.
Published: (2019-11-01) -
YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway
by: Qiu D, et al.
Published: (2020-11-01) -
MicroRNAs as regulators of ERK/MAPK pathway: A comprehensive review
by: Amin Safa, et al.
Published: (2020-12-01)